Daklibiox

Daclatavir in combination with sofosbuvir: Most common adverse reactions (≥10%) observed were headache and fatigue and nausea.

Daclatasvir in combination with peginterferon alfa and ribavirin:The most frequently reported adverse reactions were fatigue, headache, pruritus, anaemia, influenza-like illness, nausea, insomnia, neutropenia, asthenia, rash, decreased appetite, dry skin, alopecia, pyrexia, myalgia, irritability, cough, diarrhoea, dyspnoea and arthralgia.